Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
ProceedingsPoster Presentations
Open Access

Ozone and Fine Particulate Matter Components of Air Pollution Are Associated with Systemic Lupus Erythematosus Risk

Naizhuo Zhao, Sasha Bernatsky, Sharon Dowell, Brittany Banbury, Jeffrey Curtis, Grace Wright, Emily Holladay, Amy Mudano, Cristiano Soares de Moura and Gail Kerr
The Journal of Rheumatology August 2026, 53 (Suppl 1) 146; DOI: https://doi.org/10.3899/jrheum.2026-0447.192
Naizhuo Zhao
Research Institute of the McGill University Health Centre, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sasha Bernatsky
McGill University Health Centre, Department of Medicine, Division of Rheumatology, Division of Clinical Epidemiology, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Dowell
NEA Baptist Memorial Hospital, Jonesboro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany Banbury
Mount Sinai, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Curtis
Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grace Wright
Private Practice, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Holladay
University of Alabama at Birmingham, Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Mudano
Foundation for Advancing Science, Technology, Education and Research (FASTER), Hoover
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristiano Soares de Moura
The Research Institute of the McGill University Health Centre, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail Kerr
VAMC/GTU/HUH, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Previous
Loading

Abstract

Objectives Concerns are growing regarding the relationship of air pollution (especially fine particulate matter, PM2.5) in diseases like systemic lupus erythematosus (SLE). It is unclear which chemical components of ambient PM2.5 may be most harmful, and whether other air pollutants play additional roles. We aimed to evaluate the association between the mixture of PM2.5 components and SLE onset, quantifying their relative contributions to SLE risk, and potential effect modification by ambient ozone levels.

Methods Using MarketScan® administrative health data, we assembled an urban open cohort of all enrollees ≥18-year-old (without prior SLE) with residential core-based statistical area (CBSA) information. Each year after 2013, eligible individuals entered the cohort and were followed until SLE onset, death, insurance disenrollment, or study end (Dec. 2023). SLE incident cases were identified by ≥1 hospitalization or ≥2 physician billing diagnostic codes. From the cohort, all SLE cases and a 20% random baseline sub-cohort were combined into a case-cohort sample. Concentrations of PM2.5 components (ammonium, black carbon, mineral dust, sulfate, nitrate, organic matter, sea salt) and ambient ozone for 2 years before cohort entry were estimated by satellite- and ground-based models and assigned based on CBSAs at cohort entry. Extended quantile g-computation models assessed potential associations of SLE onset with the mixture of PM2.5components, ozone and their interaction, adjusting for sex, age, baseline chronic obstructive pulmonary disease (as a proxy for smoking), geographic region, and year of cohort entry. Index weights estimated by quantile g-computation models quantified the relative contributions of individual PM2.5 components to SLE risk.

Results Our case-cohort sample numbered 8,345,067 individuals including 21,485 new SLE cases. At the median ozone referent level (ie, 36.1 parts per billion), the adjusted hazard ratio for SLE onset was 1.142 (95% confidence interval, CI 1.107-1.179) per every quartile increase in all PM2.5 components (Table 1). Ozone was also associated with increased risk of SLE (HR 1.009, 95% CI 1.001-1.017). There was effect modification such that the HR for PM2.5 was highest when ozone level was lowest (Table 1). Similar results were seen in sub-groups stratified by sex or age. Mineral dust consistently had the largest index weight across different sub-groups and ozone levels.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Systemic Lupus Erythematosus Risk: Hazard Ration (HR) estimates for effects of PM2.5 component mixture, ozone, and the interaction between the exposures, at different referent levels of ozone.

Conclusion PM2.5 and ozone were associated with SLE onset; mineral dust was an important contributor. Mineral dust triggers pulmonary inflammation and is a plausible trigger of autoimmunity and SLE onset. Addressing sources of ambient mineral dust (road traffic, construction, farming) may help reduce SLE incidence.

  • Copyright © 2026 by the Journal of Rheumatology

This is an Open Access article, which permits use, distribution, and reproduction, without modification, provided the original article is correctly cited and is not used for commercial purposes.

Previous
Back to top

In this issue

The Journal of Rheumatology: 53 (Suppl 1)
The Journal of Rheumatology
Vol. 53, Issue Suppl 1
1 Aug 2026
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
  • Front Matter (PDF)
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ozone and Fine Particulate Matter Components of Air Pollution Are Associated with Systemic Lupus Erythematosus Risk
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Ozone and Fine Particulate Matter Components of Air Pollution Are Associated with Systemic Lupus Erythematosus Risk
Naizhuo Zhao, Sasha Bernatsky, Sharon Dowell, Brittany Banbury, Jeffrey Curtis, Grace Wright, Emily Holladay, Amy Mudano, Cristiano Soares de Moura, Gail Kerr
The Journal of Rheumatology Aug 2026, 53 (Suppl 1) 146; DOI: 10.3899/jrheum.2026-0447.192

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Ozone and Fine Particulate Matter Components of Air Pollution Are Associated with Systemic Lupus Erythematosus Risk
Naizhuo Zhao, Sasha Bernatsky, Sharon Dowell, Brittany Banbury, Jeffrey Curtis, Grace Wright, Emily Holladay, Amy Mudano, Cristiano Soares de Moura, Gail Kerr
The Journal of Rheumatology Aug 2026, 53 (Suppl 1) 146; DOI: 10.3899/jrheum.2026-0447.192
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • IgG4-Related Skin Disease in a 9-Year-Old Patient: Remission Under Mycophenolate Mofetil After Rituximab Failure
  • Clinical Relevance of Pelvic and Heel Enthesophytes in Psoriatic Arthritis
  • Addressing Symptoms of Burnout Among Pediatric Rheumatology Fellows: A Quality Improvement Project
Show more Poster Presentations

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire